MIRANDA LEWIS: Open Payments
NPI 1982365946 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 23 payments from 9 companies in 2025. Trend: 2023 $265 · 2024 $401 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Novo Nordisk Inc | 2 | $53 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 2 | $30 |
| GENZYME CORPORATION | 1 | $25 |
| Astellas Pharma US Inc | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, Ozempic, FABRAZYME, Veozah, IBSRELA, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
